nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Alzheimer's disease	0.302	1	CbGaD
Cevimeline—CYP2D6—Rivastigmine—Alzheimer's disease	0.0968	0.264	CbGbCtD
Cevimeline—CYP2D6—Donepezil—Alzheimer's disease	0.0774	0.211	CbGbCtD
Cevimeline—CYP3A4—Rivastigmine—Alzheimer's disease	0.0615	0.168	CbGbCtD
Cevimeline—CYP2D6—Galantamine—Alzheimer's disease	0.0498	0.136	CbGbCtD
Cevimeline—CYP3A4—Donepezil—Alzheimer's disease	0.0492	0.134	CbGbCtD
Cevimeline—CYP3A4—Galantamine—Alzheimer's disease	0.0317	0.0865	CbGbCtD
Cevimeline—FMO1—forebrain—Alzheimer's disease	0.00136	0.153	CbGeAlD
Cevimeline—FMO1—nervous system—Alzheimer's disease	0.000738	0.0829	CbGeAlD
Cevimeline—FMO1—central nervous system—Alzheimer's disease	0.000711	0.0798	CbGeAlD
Cevimeline—CHRM1—forebrain—Alzheimer's disease	0.000624	0.0701	CbGeAlD
Cevimeline—CHRM1—telencephalon—Alzheimer's disease	0.000574	0.0645	CbGeAlD
Cevimeline—FMO1—brain—Alzheimer's disease	0.000564	0.0634	CbGeAlD
Cevimeline—CHRM3—forebrain—Alzheimer's disease	0.000559	0.0627	CbGeAlD
Cevimeline—CHRM3—telencephalon—Alzheimer's disease	0.000514	0.0577	CbGeAlD
Cevimeline—CHRM1—nervous system—Alzheimer's disease	0.000339	0.0381	CbGeAlD
Cevimeline—CHRM1—central nervous system—Alzheimer's disease	0.000326	0.0366	CbGeAlD
Cevimeline—CHRM3—nervous system—Alzheimer's disease	0.000303	0.0341	CbGeAlD
Cevimeline—CYP2D6—forebrain—Alzheimer's disease	0.000302	0.0339	CbGeAlD
Cevimeline—CHRM3—central nervous system—Alzheimer's disease	0.000292	0.0328	CbGeAlD
Cevimeline—CYP2D6—telencephalon—Alzheimer's disease	0.000278	0.0312	CbGeAlD
Cevimeline—CHRM1—brain—Alzheimer's disease	0.000259	0.0291	CbGeAlD
Cevimeline—CHRM3—brain—Alzheimer's disease	0.000232	0.026	CbGeAlD
Cevimeline—CYP3A4—nervous system—Alzheimer's disease	0.000167	0.0187	CbGeAlD
Cevimeline—CYP2D6—nervous system—Alzheimer's disease	0.000164	0.0184	CbGeAlD
Cevimeline—CYP3A4—central nervous system—Alzheimer's disease	0.00016	0.018	CbGeAlD
Cevimeline—CYP2D6—central nervous system—Alzheimer's disease	0.000158	0.0177	CbGeAlD
Cevimeline—CYP2D6—cerebellum—Alzheimer's disease	0.000154	0.0173	CbGeAlD
Cevimeline—Chest pain—Galantamine—Alzheimer's disease	0.000153	0.000516	CcSEcCtD
Cevimeline—Myalgia—Galantamine—Alzheimer's disease	0.000153	0.000516	CcSEcCtD
Cevimeline—Arthralgia—Galantamine—Alzheimer's disease	0.000153	0.000516	CcSEcCtD
Cevimeline—Epistaxis—Memantine—Alzheimer's disease	0.000153	0.000515	CcSEcCtD
Cevimeline—Anxiety—Galantamine—Alzheimer's disease	0.000153	0.000514	CcSEcCtD
Cevimeline—Sinusitis—Memantine—Alzheimer's disease	0.000152	0.000512	CcSEcCtD
Cevimeline—Discomfort—Galantamine—Alzheimer's disease	0.000152	0.00051	CcSEcCtD
Cevimeline—Agranulocytosis—Memantine—Alzheimer's disease	0.000151	0.000509	CcSEcCtD
Cevimeline—Haematuria—Rivastigmine—Alzheimer's disease	0.000151	0.000509	CcSEcCtD
Cevimeline—Epistaxis—Rivastigmine—Alzheimer's disease	0.00015	0.000503	CcSEcCtD
Cevimeline—Tinnitus—Donepezil—Alzheimer's disease	0.00015	0.000503	CcSEcCtD
Cevimeline—Sinusitis—Rivastigmine—Alzheimer's disease	0.000149	0.000501	CcSEcCtD
Cevimeline—Confusional state—Galantamine—Alzheimer's disease	0.000148	0.000499	CcSEcCtD
Cevimeline—Haemoglobin—Memantine—Alzheimer's disease	0.000146	0.000492	CcSEcCtD
Cevimeline—Rhinitis—Memantine—Alzheimer's disease	0.000146	0.000491	CcSEcCtD
Cevimeline—Haemorrhage—Memantine—Alzheimer's disease	0.000146	0.00049	CcSEcCtD
Cevimeline—Hypoaesthesia—Memantine—Alzheimer's disease	0.000145	0.000487	CcSEcCtD
Cevimeline—Hallucination—Memantine—Alzheimer's disease	0.000145	0.000487	CcSEcCtD
Cevimeline—Shock—Galantamine—Alzheimer's disease	0.000145	0.000487	CcSEcCtD
Cevimeline—Pharyngitis—Memantine—Alzheimer's disease	0.000145	0.000486	CcSEcCtD
Cevimeline—Nervous system disorder—Galantamine—Alzheimer's disease	0.000144	0.000485	CcSEcCtD
Cevimeline—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000144	0.000484	CcSEcCtD
Cevimeline—Chills—Donepezil—Alzheimer's disease	0.000144	0.000484	CcSEcCtD
Cevimeline—Tachycardia—Galantamine—Alzheimer's disease	0.000144	0.000483	CcSEcCtD
Cevimeline—Oedema peripheral—Memantine—Alzheimer's disease	0.000144	0.000482	CcSEcCtD
Cevimeline—Arrhythmia—Donepezil—Alzheimer's disease	0.000143	0.000482	CcSEcCtD
Cevimeline—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000143	0.000482	CcSEcCtD
Cevimeline—Rhinitis—Rivastigmine—Alzheimer's disease	0.000143	0.00048	CcSEcCtD
Cevimeline—Skin disorder—Galantamine—Alzheimer's disease	0.000143	0.00048	CcSEcCtD
Cevimeline—Urethral disorder—Memantine—Alzheimer's disease	0.000143	0.00048	CcSEcCtD
Cevimeline—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000143	0.000479	CcSEcCtD
Cevimeline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000142	0.000478	CcSEcCtD
Cevimeline—Hallucination—Rivastigmine—Alzheimer's disease	0.000142	0.000477	CcSEcCtD
Cevimeline—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000142	0.000477	CcSEcCtD
Cevimeline—Alopecia—Donepezil—Alzheimer's disease	0.000142	0.000477	CcSEcCtD
Cevimeline—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000141	0.000476	CcSEcCtD
Cevimeline—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00014	0.000472	CcSEcCtD
Cevimeline—Visual impairment—Memantine—Alzheimer's disease	0.00014	0.000472	CcSEcCtD
Cevimeline—Anorexia—Galantamine—Alzheimer's disease	0.00014	0.000471	CcSEcCtD
Cevimeline—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00014	0.00047	CcSEcCtD
Cevimeline—Malnutrition—Donepezil—Alzheimer's disease	0.00014	0.00047	CcSEcCtD
Cevimeline—Flatulence—Donepezil—Alzheimer's disease	0.000138	0.000463	CcSEcCtD
Cevimeline—Hypotension—Galantamine—Alzheimer's disease	0.000137	0.000462	CcSEcCtD
Cevimeline—Visual impairment—Rivastigmine—Alzheimer's disease	0.000137	0.000462	CcSEcCtD
Cevimeline—Dysgeusia—Donepezil—Alzheimer's disease	0.000137	0.00046	CcSEcCtD
Cevimeline—Eye disorder—Memantine—Alzheimer's disease	0.000136	0.000458	CcSEcCtD
Cevimeline—Tinnitus—Memantine—Alzheimer's disease	0.000136	0.000457	CcSEcCtD
Cevimeline—Flushing—Memantine—Alzheimer's disease	0.000135	0.000455	CcSEcCtD
Cevimeline—Cardiac disorder—Memantine—Alzheimer's disease	0.000135	0.000455	CcSEcCtD
Cevimeline—Back pain—Donepezil—Alzheimer's disease	0.000135	0.000454	CcSEcCtD
Cevimeline—Muscle spasms—Donepezil—Alzheimer's disease	0.000134	0.000451	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000134	0.000451	CcSEcCtD
Cevimeline—Eye disorder—Rivastigmine—Alzheimer's disease	0.000133	0.000448	CcSEcCtD
Cevimeline—Insomnia—Galantamine—Alzheimer's disease	0.000133	0.000447	CcSEcCtD
Cevimeline—Tinnitus—Rivastigmine—Alzheimer's disease	0.000133	0.000447	CcSEcCtD
Cevimeline—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000132	0.000445	CcSEcCtD
Cevimeline—Flushing—Rivastigmine—Alzheimer's disease	0.000132	0.000445	CcSEcCtD
Cevimeline—Angiopathy—Memantine—Alzheimer's disease	0.000132	0.000444	CcSEcCtD
Cevimeline—Paraesthesia—Galantamine—Alzheimer's disease	0.000132	0.000444	CcSEcCtD
Cevimeline—Tremor—Donepezil—Alzheimer's disease	0.000131	0.00044	CcSEcCtD
Cevimeline—Somnolence—Galantamine—Alzheimer's disease	0.000131	0.00044	CcSEcCtD
Cevimeline—Chills—Memantine—Alzheimer's disease	0.000131	0.000439	CcSEcCtD
Cevimeline—Arrhythmia—Memantine—Alzheimer's disease	0.00013	0.000438	CcSEcCtD
Cevimeline—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00013	0.000436	CcSEcCtD
Cevimeline—Dyspepsia—Galantamine—Alzheimer's disease	0.000129	0.000435	CcSEcCtD
Cevimeline—Angiopathy—Rivastigmine—Alzheimer's disease	0.000129	0.000435	CcSEcCtD
Cevimeline—Anaemia—Donepezil—Alzheimer's disease	0.000129	0.000434	CcSEcCtD
Cevimeline—Alopecia—Memantine—Alzheimer's disease	0.000129	0.000433	CcSEcCtD
Cevimeline—Agitation—Donepezil—Alzheimer's disease	0.000128	0.000432	CcSEcCtD
Cevimeline—Chills—Rivastigmine—Alzheimer's disease	0.000128	0.00043	CcSEcCtD
Cevimeline—Decreased appetite—Galantamine—Alzheimer's disease	0.000128	0.00043	CcSEcCtD
Cevimeline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000127	0.000428	CcSEcCtD
Cevimeline—Malnutrition—Memantine—Alzheimer's disease	0.000127	0.000426	CcSEcCtD
Cevimeline—Fatigue—Galantamine—Alzheimer's disease	0.000127	0.000426	CcSEcCtD
Cevimeline—Malaise—Donepezil—Alzheimer's disease	0.000126	0.000423	CcSEcCtD
Cevimeline—Alopecia—Rivastigmine—Alzheimer's disease	0.000126	0.000423	CcSEcCtD
Cevimeline—Constipation—Galantamine—Alzheimer's disease	0.000126	0.000423	CcSEcCtD
Cevimeline—Vertigo—Donepezil—Alzheimer's disease	0.000125	0.000422	CcSEcCtD
Cevimeline—CYP2D6—brain—Alzheimer's disease	0.000125	0.0141	CbGeAlD
Cevimeline—Syncope—Donepezil—Alzheimer's disease	0.000125	0.000421	CcSEcCtD
Cevimeline—Flatulence—Memantine—Alzheimer's disease	0.000125	0.00042	CcSEcCtD
Cevimeline—Dysgeusia—Memantine—Alzheimer's disease	0.000124	0.000418	CcSEcCtD
Cevimeline—Malnutrition—Rivastigmine—Alzheimer's disease	0.000124	0.000417	CcSEcCtD
Cevimeline—Loss of consciousness—Donepezil—Alzheimer's disease	0.000123	0.000413	CcSEcCtD
Cevimeline—Back pain—Memantine—Alzheimer's disease	0.000123	0.000412	CcSEcCtD
Cevimeline—Flatulence—Rivastigmine—Alzheimer's disease	0.000122	0.000411	CcSEcCtD
Cevimeline—Cough—Donepezil—Alzheimer's disease	0.000122	0.00041	CcSEcCtD
Cevimeline—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000121	0.000408	CcSEcCtD
Cevimeline—Feeling abnormal—Galantamine—Alzheimer's disease	0.000121	0.000408	CcSEcCtD
Cevimeline—Convulsion—Donepezil—Alzheimer's disease	0.000121	0.000407	CcSEcCtD
Cevimeline—Hypertension—Donepezil—Alzheimer's disease	0.000121	0.000405	CcSEcCtD
Cevimeline—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00012	0.000404	CcSEcCtD
Cevimeline—Back pain—Rivastigmine—Alzheimer's disease	0.00012	0.000403	CcSEcCtD
Cevimeline—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000119	0.000401	CcSEcCtD
Cevimeline—Chest pain—Donepezil—Alzheimer's disease	0.000119	0.0004	CcSEcCtD
Cevimeline—Myalgia—Donepezil—Alzheimer's disease	0.000119	0.0004	CcSEcCtD
Cevimeline—Arthralgia—Donepezil—Alzheimer's disease	0.000119	0.0004	CcSEcCtD
Cevimeline—Tremor—Memantine—Alzheimer's disease	0.000119	0.000399	CcSEcCtD
Cevimeline—Anxiety—Donepezil—Alzheimer's disease	0.000118	0.000398	CcSEcCtD
Cevimeline—Ill-defined disorder—Memantine—Alzheimer's disease	0.000118	0.000396	CcSEcCtD
Cevimeline—Discomfort—Donepezil—Alzheimer's disease	0.000117	0.000395	CcSEcCtD
Cevimeline—Anaemia—Memantine—Alzheimer's disease	0.000117	0.000394	CcSEcCtD
Cevimeline—Agitation—Memantine—Alzheimer's disease	0.000117	0.000392	CcSEcCtD
Cevimeline—Body temperature increased—Galantamine—Alzheimer's disease	0.000116	0.000391	CcSEcCtD
Cevimeline—Abdominal pain—Galantamine—Alzheimer's disease	0.000116	0.000391	CcSEcCtD
Cevimeline—Tremor—Rivastigmine—Alzheimer's disease	0.000116	0.000391	CcSEcCtD
Cevimeline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000115	0.000387	CcSEcCtD
Cevimeline—Confusional state—Donepezil—Alzheimer's disease	0.000115	0.000386	CcSEcCtD
Cevimeline—Anaemia—Rivastigmine—Alzheimer's disease	0.000115	0.000386	CcSEcCtD
Cevimeline—Malaise—Memantine—Alzheimer's disease	0.000114	0.000384	CcSEcCtD
Cevimeline—Agitation—Rivastigmine—Alzheimer's disease	0.000114	0.000383	CcSEcCtD
Cevimeline—Oedema—Donepezil—Alzheimer's disease	0.000114	0.000383	CcSEcCtD
Cevimeline—Vertigo—Memantine—Alzheimer's disease	0.000114	0.000383	CcSEcCtD
Cevimeline—Syncope—Memantine—Alzheimer's disease	0.000114	0.000382	CcSEcCtD
Cevimeline—Leukopenia—Memantine—Alzheimer's disease	0.000114	0.000382	CcSEcCtD
Cevimeline—Infection—Donepezil—Alzheimer's disease	0.000113	0.000381	CcSEcCtD
Cevimeline—Shock—Donepezil—Alzheimer's disease	0.000112	0.000377	CcSEcCtD
Cevimeline—Palpitations—Memantine—Alzheimer's disease	0.000112	0.000377	CcSEcCtD
Cevimeline—Malaise—Rivastigmine—Alzheimer's disease	0.000112	0.000376	CcSEcCtD
Cevimeline—Nervous system disorder—Donepezil—Alzheimer's disease	0.000112	0.000376	CcSEcCtD
Cevimeline—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000112	0.000375	CcSEcCtD
Cevimeline—Vertigo—Rivastigmine—Alzheimer's disease	0.000111	0.000375	CcSEcCtD
Cevimeline—Loss of consciousness—Memantine—Alzheimer's disease	0.000111	0.000375	CcSEcCtD
Cevimeline—Syncope—Rivastigmine—Alzheimer's disease	0.000111	0.000374	CcSEcCtD
Cevimeline—Cough—Memantine—Alzheimer's disease	0.000111	0.000372	CcSEcCtD
Cevimeline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00011	0.00037	CcSEcCtD
Cevimeline—Convulsion—Memantine—Alzheimer's disease	0.00011	0.000369	CcSEcCtD
Cevimeline—Palpitations—Rivastigmine—Alzheimer's disease	0.00011	0.000369	CcSEcCtD
Cevimeline—Hypertension—Memantine—Alzheimer's disease	0.000109	0.000368	CcSEcCtD
Cevimeline—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000109	0.000367	CcSEcCtD
Cevimeline—Anorexia—Donepezil—Alzheimer's disease	0.000109	0.000365	CcSEcCtD
Cevimeline—Hypersensitivity—Galantamine—Alzheimer's disease	0.000108	0.000364	CcSEcCtD
Cevimeline—Cough—Rivastigmine—Alzheimer's disease	0.000108	0.000364	CcSEcCtD
Cevimeline—Arthralgia—Memantine—Alzheimer's disease	0.000108	0.000363	CcSEcCtD
Cevimeline—Chest pain—Memantine—Alzheimer's disease	0.000108	0.000363	CcSEcCtD
Cevimeline—Myalgia—Memantine—Alzheimer's disease	0.000108	0.000363	CcSEcCtD
Cevimeline—Anxiety—Memantine—Alzheimer's disease	0.000108	0.000362	CcSEcCtD
Cevimeline—Convulsion—Rivastigmine—Alzheimer's disease	0.000107	0.000361	CcSEcCtD
Cevimeline—Hypertension—Rivastigmine—Alzheimer's disease	0.000107	0.00036	CcSEcCtD
Cevimeline—Discomfort—Memantine—Alzheimer's disease	0.000107	0.000359	CcSEcCtD
Cevimeline—Hypotension—Donepezil—Alzheimer's disease	0.000107	0.000358	CcSEcCtD
Cevimeline—Arthralgia—Rivastigmine—Alzheimer's disease	0.000106	0.000355	CcSEcCtD
Cevimeline—Myalgia—Rivastigmine—Alzheimer's disease	0.000106	0.000355	CcSEcCtD
Cevimeline—Chest pain—Rivastigmine—Alzheimer's disease	0.000106	0.000355	CcSEcCtD
Cevimeline—Asthenia—Galantamine—Alzheimer's disease	0.000106	0.000355	CcSEcCtD
Cevimeline—Anxiety—Rivastigmine—Alzheimer's disease	0.000105	0.000354	CcSEcCtD
Cevimeline—Confusional state—Memantine—Alzheimer's disease	0.000104	0.000351	CcSEcCtD
Cevimeline—Discomfort—Rivastigmine—Alzheimer's disease	0.000104	0.000351	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000104	0.000349	CcSEcCtD
Cevimeline—Oedema—Memantine—Alzheimer's disease	0.000103	0.000348	CcSEcCtD
Cevimeline—Insomnia—Donepezil—Alzheimer's disease	0.000103	0.000347	CcSEcCtD
Cevimeline—Infection—Memantine—Alzheimer's disease	0.000103	0.000346	CcSEcCtD
Cevimeline—Paraesthesia—Donepezil—Alzheimer's disease	0.000102	0.000344	CcSEcCtD
Cevimeline—Confusional state—Rivastigmine—Alzheimer's disease	0.000102	0.000343	CcSEcCtD
Cevimeline—Shock—Memantine—Alzheimer's disease	0.000102	0.000342	CcSEcCtD
Cevimeline—Dyspnoea—Donepezil—Alzheimer's disease	0.000102	0.000342	CcSEcCtD
Cevimeline—Nervous system disorder—Memantine—Alzheimer's disease	0.000101	0.000341	CcSEcCtD
Cevimeline—Somnolence—Donepezil—Alzheimer's disease	0.000101	0.000341	CcSEcCtD
Cevimeline—Thrombocytopenia—Memantine—Alzheimer's disease	0.000101	0.000341	CcSEcCtD
Cevimeline—Oedema—Rivastigmine—Alzheimer's disease	0.000101	0.00034	CcSEcCtD
Cevimeline—Tachycardia—Memantine—Alzheimer's disease	0.000101	0.00034	CcSEcCtD
Cevimeline—Diarrhoea—Galantamine—Alzheimer's disease	0.000101	0.000338	CcSEcCtD
Cevimeline—Infection—Rivastigmine—Alzheimer's disease	0.000101	0.000338	CcSEcCtD
Cevimeline—Skin disorder—Memantine—Alzheimer's disease	0.000101	0.000338	CcSEcCtD
Cevimeline—Dyspepsia—Donepezil—Alzheimer's disease	0.0001	0.000337	CcSEcCtD
Cevimeline—Hyperhidrosis—Memantine—Alzheimer's disease	0.0001	0.000336	CcSEcCtD
Cevimeline—Shock—Rivastigmine—Alzheimer's disease	9.96e-05	0.000335	CcSEcCtD
Cevimeline—Nervous system disorder—Rivastigmine—Alzheimer's disease	9.93e-05	0.000334	CcSEcCtD
Cevimeline—Thrombocytopenia—Rivastigmine—Alzheimer's disease	9.91e-05	0.000333	CcSEcCtD
Cevimeline—Decreased appetite—Donepezil—Alzheimer's disease	9.91e-05	0.000333	CcSEcCtD
Cevimeline—Tachycardia—Rivastigmine—Alzheimer's disease	9.88e-05	0.000332	CcSEcCtD
Cevimeline—Anorexia—Memantine—Alzheimer's disease	9.87e-05	0.000332	CcSEcCtD
Cevimeline—Skin disorder—Rivastigmine—Alzheimer's disease	9.83e-05	0.000331	CcSEcCtD
Cevimeline—Fatigue—Donepezil—Alzheimer's disease	9.83e-05	0.00033	CcSEcCtD
Cevimeline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	9.79e-05	0.000329	CcSEcCtD
Cevimeline—Pain—Donepezil—Alzheimer's disease	9.75e-05	0.000328	CcSEcCtD
Cevimeline—Constipation—Donepezil—Alzheimer's disease	9.75e-05	0.000328	CcSEcCtD
Cevimeline—Dizziness—Galantamine—Alzheimer's disease	9.73e-05	0.000327	CcSEcCtD
Cevimeline—Hypotension—Memantine—Alzheimer's disease	9.67e-05	0.000325	CcSEcCtD
Cevimeline—Anorexia—Rivastigmine—Alzheimer's disease	9.65e-05	0.000324	CcSEcCtD
Cevimeline—Hypotension—Rivastigmine—Alzheimer's disease	9.46e-05	0.000318	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Memantine—Alzheimer's disease	9.43e-05	0.000317	CcSEcCtD
Cevimeline—Feeling abnormal—Donepezil—Alzheimer's disease	9.39e-05	0.000316	CcSEcCtD
Cevimeline—Insomnia—Memantine—Alzheimer's disease	9.36e-05	0.000315	CcSEcCtD
Cevimeline—Vomiting—Galantamine—Alzheimer's disease	9.35e-05	0.000314	CcSEcCtD
Cevimeline—Gastrointestinal pain—Donepezil—Alzheimer's disease	9.32e-05	0.000313	CcSEcCtD
Cevimeline—Paraesthesia—Memantine—Alzheimer's disease	9.29e-05	0.000312	CcSEcCtD
Cevimeline—Rash—Galantamine—Alzheimer's disease	9.27e-05	0.000312	CcSEcCtD
Cevimeline—Dermatitis—Galantamine—Alzheimer's disease	9.26e-05	0.000312	CcSEcCtD
Cevimeline—Dyspnoea—Memantine—Alzheimer's disease	9.23e-05	0.00031	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	9.22e-05	0.00031	CcSEcCtD
Cevimeline—Headache—Galantamine—Alzheimer's disease	9.21e-05	0.00031	CcSEcCtD
Cevimeline—Somnolence—Memantine—Alzheimer's disease	9.2e-05	0.000309	CcSEcCtD
Cevimeline—Insomnia—Rivastigmine—Alzheimer's disease	9.16e-05	0.000308	CcSEcCtD
Cevimeline—Dyspepsia—Memantine—Alzheimer's disease	9.11e-05	0.000306	CcSEcCtD
Cevimeline—Paraesthesia—Rivastigmine—Alzheimer's disease	9.09e-05	0.000306	CcSEcCtD
Cevimeline—Urticaria—Donepezil—Alzheimer's disease	9.06e-05	0.000304	CcSEcCtD
Cevimeline—Dyspnoea—Rivastigmine—Alzheimer's disease	9.03e-05	0.000303	CcSEcCtD
Cevimeline—Body temperature increased—Donepezil—Alzheimer's disease	9.01e-05	0.000303	CcSEcCtD
Cevimeline—Abdominal pain—Donepezil—Alzheimer's disease	9.01e-05	0.000303	CcSEcCtD
Cevimeline—Somnolence—Rivastigmine—Alzheimer's disease	9e-05	0.000303	CcSEcCtD
Cevimeline—Decreased appetite—Memantine—Alzheimer's disease	9e-05	0.000302	CcSEcCtD
Cevimeline—Fatigue—Memantine—Alzheimer's disease	8.92e-05	0.0003	CcSEcCtD
Cevimeline—Dyspepsia—Rivastigmine—Alzheimer's disease	8.91e-05	0.0003	CcSEcCtD
Cevimeline—Pain—Memantine—Alzheimer's disease	8.85e-05	0.000298	CcSEcCtD
Cevimeline—Constipation—Memantine—Alzheimer's disease	8.85e-05	0.000298	CcSEcCtD
Cevimeline—Decreased appetite—Rivastigmine—Alzheimer's disease	8.8e-05	0.000296	CcSEcCtD
Cevimeline—Nausea—Galantamine—Alzheimer's disease	8.74e-05	0.000294	CcSEcCtD
Cevimeline—Fatigue—Rivastigmine—Alzheimer's disease	8.73e-05	0.000293	CcSEcCtD
Cevimeline—Pain—Rivastigmine—Alzheimer's disease	8.66e-05	0.000291	CcSEcCtD
Cevimeline—Constipation—Rivastigmine—Alzheimer's disease	8.66e-05	0.000291	CcSEcCtD
Cevimeline—Feeling abnormal—Memantine—Alzheimer's disease	8.53e-05	0.000287	CcSEcCtD
Cevimeline—Gastrointestinal pain—Memantine—Alzheimer's disease	8.46e-05	0.000285	CcSEcCtD
Cevimeline—Hypersensitivity—Donepezil—Alzheimer's disease	8.4e-05	0.000282	CcSEcCtD
Cevimeline—Feeling abnormal—Rivastigmine—Alzheimer's disease	8.34e-05	0.000281	CcSEcCtD
Cevimeline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	8.28e-05	0.000278	CcSEcCtD
Cevimeline—Urticaria—Memantine—Alzheimer's disease	8.22e-05	0.000276	CcSEcCtD
Cevimeline—Abdominal pain—Memantine—Alzheimer's disease	8.18e-05	0.000275	CcSEcCtD
Cevimeline—Body temperature increased—Memantine—Alzheimer's disease	8.18e-05	0.000275	CcSEcCtD
Cevimeline—Asthenia—Donepezil—Alzheimer's disease	8.18e-05	0.000275	CcSEcCtD
Cevimeline—Pruritus—Donepezil—Alzheimer's disease	8.06e-05	0.000271	CcSEcCtD
Cevimeline—Urticaria—Rivastigmine—Alzheimer's disease	8.04e-05	0.00027	CcSEcCtD
Cevimeline—Abdominal pain—Rivastigmine—Alzheimer's disease	8e-05	0.000269	CcSEcCtD
Cevimeline—Body temperature increased—Rivastigmine—Alzheimer's disease	8e-05	0.000269	CcSEcCtD
Cevimeline—Diarrhoea—Donepezil—Alzheimer's disease	7.8e-05	0.000262	CcSEcCtD
Cevimeline—Hypersensitivity—Memantine—Alzheimer's disease	7.62e-05	0.000256	CcSEcCtD
Cevimeline—Dizziness—Donepezil—Alzheimer's disease	7.54e-05	0.000253	CcSEcCtD
Cevimeline—Hypersensitivity—Rivastigmine—Alzheimer's disease	7.46e-05	0.000251	CcSEcCtD
Cevimeline—Asthenia—Memantine—Alzheimer's disease	7.43e-05	0.00025	CcSEcCtD
Cevimeline—Pruritus—Memantine—Alzheimer's disease	7.32e-05	0.000246	CcSEcCtD
Cevimeline—Asthenia—Rivastigmine—Alzheimer's disease	7.26e-05	0.000244	CcSEcCtD
Cevimeline—Vomiting—Donepezil—Alzheimer's disease	7.25e-05	0.000244	CcSEcCtD
Cevimeline—Rash—Donepezil—Alzheimer's disease	7.19e-05	0.000242	CcSEcCtD
Cevimeline—Dermatitis—Donepezil—Alzheimer's disease	7.18e-05	0.000241	CcSEcCtD
Cevimeline—Pruritus—Rivastigmine—Alzheimer's disease	7.16e-05	0.000241	CcSEcCtD
Cevimeline—Headache—Donepezil—Alzheimer's disease	7.14e-05	0.00024	CcSEcCtD
Cevimeline—Diarrhoea—Memantine—Alzheimer's disease	7.08e-05	0.000238	CcSEcCtD
Cevimeline—Diarrhoea—Rivastigmine—Alzheimer's disease	6.93e-05	0.000233	CcSEcCtD
Cevimeline—Dizziness—Memantine—Alzheimer's disease	6.84e-05	0.00023	CcSEcCtD
Cevimeline—Nausea—Donepezil—Alzheimer's disease	6.77e-05	0.000228	CcSEcCtD
Cevimeline—Dizziness—Rivastigmine—Alzheimer's disease	6.7e-05	0.000225	CcSEcCtD
Cevimeline—Vomiting—Memantine—Alzheimer's disease	6.58e-05	0.000221	CcSEcCtD
Cevimeline—Rash—Memantine—Alzheimer's disease	6.53e-05	0.000219	CcSEcCtD
Cevimeline—Dermatitis—Memantine—Alzheimer's disease	6.52e-05	0.000219	CcSEcCtD
Cevimeline—Headache—Memantine—Alzheimer's disease	6.48e-05	0.000218	CcSEcCtD
Cevimeline—Vomiting—Rivastigmine—Alzheimer's disease	6.44e-05	0.000216	CcSEcCtD
Cevimeline—Rash—Rivastigmine—Alzheimer's disease	6.38e-05	0.000215	CcSEcCtD
Cevimeline—Dermatitis—Rivastigmine—Alzheimer's disease	6.38e-05	0.000214	CcSEcCtD
Cevimeline—Headache—Rivastigmine—Alzheimer's disease	6.34e-05	0.000213	CcSEcCtD
Cevimeline—Nausea—Memantine—Alzheimer's disease	6.15e-05	0.000207	CcSEcCtD
Cevimeline—Nausea—Rivastigmine—Alzheimer's disease	6.01e-05	0.000202	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—CRH—Alzheimer's disease	1.87e-05	0.000729	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	1.86e-05	0.000728	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—SST—Alzheimer's disease	1.86e-05	0.000728	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GAB2—Alzheimer's disease	1.86e-05	0.000726	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—SST—Alzheimer's disease	1.86e-05	0.000726	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDK5—Alzheimer's disease	1.83e-05	0.000713	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—F2—Alzheimer's disease	1.82e-05	0.000712	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDK5—Alzheimer's disease	1.82e-05	0.000711	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—F2—Alzheimer's disease	1.82e-05	0.00071	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—APP—Alzheimer's disease	1.82e-05	0.00071	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—APP—Alzheimer's disease	1.81e-05	0.000707	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.79e-05	0.000699	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—NPS—Alzheimer's disease	1.78e-05	0.000693	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—NPS—Alzheimer's disease	1.77e-05	0.000691	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.77e-05	0.00069	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.76e-05	0.000688	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR6—Alzheimer's disease	1.76e-05	0.000686	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR6—Alzheimer's disease	1.75e-05	0.000684	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TPI1—Alzheimer's disease	1.72e-05	0.000672	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CHAT—Alzheimer's disease	1.72e-05	0.000672	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.72e-05	0.000671	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.71e-05	0.00067	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.71e-05	0.000668	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GAB2—Alzheimer's disease	1.69e-05	0.000661	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SST—Alzheimer's disease	1.69e-05	0.000661	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SST—Alzheimer's disease	1.69e-05	0.000659	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GAB2—Alzheimer's disease	1.69e-05	0.000659	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.65e-05	0.000646	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—APP—Alzheimer's disease	1.65e-05	0.000644	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOB—Alzheimer's disease	1.65e-05	0.000644	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—APP—Alzheimer's disease	1.65e-05	0.000642	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCL2—Alzheimer's disease	1.63e-05	0.000635	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCL2—Alzheimer's disease	1.62e-05	0.000633	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.62e-05	0.000633	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.6e-05	0.000623	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PSENEN—Alzheimer's disease	1.6e-05	0.000623	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PSENEN—Alzheimer's disease	1.59e-05	0.000621	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GAPDH—Alzheimer's disease	1.59e-05	0.00062	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APH1A—Alzheimer's disease	1.57e-05	0.000615	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APH1A—Alzheimer's disease	1.57e-05	0.000613	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.56e-05	0.000608	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PLCB1—Alzheimer's disease	1.55e-05	0.000606	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—A2M—Alzheimer's disease	1.53e-05	0.000599	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NCSTN—Alzheimer's disease	1.53e-05	0.000598	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NCSTN—Alzheimer's disease	1.53e-05	0.000596	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LRP1—Alzheimer's disease	1.49e-05	0.000584	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LRP1—Alzheimer's disease	1.49e-05	0.000582	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—Alzheimer's disease	1.48e-05	0.000577	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	1.46e-05	0.00057	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	1.46e-05	0.00057	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	1.46e-05	0.000568	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	1.46e-05	0.000568	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.38e-05	0.000538	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	1.35e-05	0.000528	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ACHE—Alzheimer's disease	1.33e-05	0.000521	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INPP5D—Alzheimer's disease	1.32e-05	0.000515	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.29e-05	0.000506	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	1.29e-05	0.000502	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	1.28e-05	0.000501	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.28e-05	0.0005	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.28e-05	0.000499	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.27e-05	0.000495	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.26e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS1—Alzheimer's disease	1.25e-05	0.000488	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ENO1—Alzheimer's disease	1.25e-05	0.000488	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	1.25e-05	0.000487	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	1.24e-05	0.000485	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.23e-05	0.000479	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	1.23e-05	0.000479	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.2e-05	0.000469	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	1.2e-05	0.000468	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.18e-05	0.000459	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.17e-05	0.000458	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.17e-05	0.000457	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—BCHE—Alzheimer's disease	1.16e-05	0.000454	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.15e-05	0.00045	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	1.15e-05	0.000448	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	1.15e-05	0.000448	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	1.14e-05	0.000446	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.14e-05	0.000445	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	1.14e-05	0.000444	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.12e-05	0.000438	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	1.11e-05	0.000432	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	1.1e-05	0.000431	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLCB1—Alzheimer's disease	1.1e-05	0.000428	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.09e-05	0.000426	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	1.09e-05	0.000425	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.08e-05	0.000422	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.07e-05	0.000417	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.06e-05	0.000416	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCA1—Alzheimer's disease	1.06e-05	0.000415	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.05e-05	0.00041	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	1.05e-05	0.000408	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.04e-05	0.000408	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.04e-05	0.000407	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.04e-05	0.000406	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.03e-05	0.000403	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.03e-05	0.000402	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.03e-05	0.000402	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.03e-05	0.000402	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	1.03e-05	0.000401	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	1.03e-05	0.0004	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1e-05	0.000391	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1e-05	0.000391	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1e-05	0.000391	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	9.97e-06	0.000389	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	9.97e-06	0.000389	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SST—Alzheimer's disease	9.97e-06	0.000389	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	9.96e-06	0.000389	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	9.93e-06	0.000388	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	9.92e-06	0.000387	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	9.89e-06	0.000386	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.86e-06	0.000385	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APP—Alzheimer's disease	9.75e-06	0.000381	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APP—Alzheimer's disease	9.72e-06	0.000379	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—Alzheimer's disease	9.68e-06	0.000378	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.49e-06	0.000371	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	9.36e-06	0.000366	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	9.33e-06	0.000364	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	9.2e-06	0.000359	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	9.17e-06	0.000358	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.17e-06	0.000358	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	9.16e-06	0.000358	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—Alzheimer's disease	9.12e-06	0.000356	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	8.58e-06	0.000335	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	8.56e-06	0.000334	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	8.53e-06	0.000333	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	8.5e-06	0.000332	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	8.38e-06	0.000327	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	8.36e-06	0.000326	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	8.35e-06	0.000326	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LPL—Alzheimer's disease	8.34e-06	0.000326	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	8.32e-06	0.000325	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.98e-06	0.000312	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	7.93e-06	0.00031	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	7.9e-06	0.000309	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.89e-06	0.000308	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	7.55e-06	0.000295	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	7.52e-06	0.000294	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—Alzheimer's disease	7.51e-06	0.000293	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.48e-06	0.000292	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.48e-06	0.000292	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	7.3e-06	0.000285	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	7.28e-06	0.000284	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CALM1—Alzheimer's disease	7.02e-06	0.000274	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	7e-06	0.000273	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—Alzheimer's disease	6.99e-06	0.000273	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	6.97e-06	0.000272	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.95e-06	0.000271	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	6.93e-06	0.000271	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—Alzheimer's disease	6.93e-06	0.000271	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	6.91e-06	0.00027	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	6.8e-06	0.000266	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	6.78e-06	0.000265	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.73e-06	0.000263	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.73e-06	0.000263	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	6.63e-06	0.000259	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	6.61e-06	0.000258	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.56e-06	0.000256	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.45e-06	0.000252	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	6.45e-06	0.000252	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	6.43e-06	0.000251	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.36e-06	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	6.31e-06	0.000246	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	6.29e-06	0.000246	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.21e-06	0.000242	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—Alzheimer's disease	6.09e-06	0.000238	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—A2M—Alzheimer's disease	6e-06	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—Alzheimer's disease	5.97e-06	0.000233	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	5.89e-06	0.00023	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	5.87e-06	0.000229	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	5.87e-06	0.000229	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	5.87e-06	0.000229	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	5.85e-06	0.000228	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	5.85e-06	0.000228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	5.81e-06	0.000227	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	5.79e-06	0.000226	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	5.6e-06	0.000219	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	5.58e-06	0.000218	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2—Alzheimer's disease	5.53e-06	0.000216	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2—Alzheimer's disease	5.51e-06	0.000215	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.48e-06	0.000214	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.45e-06	0.000213	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.41e-06	0.000211	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	5.4e-06	0.000211	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—Alzheimer's disease	5.24e-06	0.000205	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.22e-06	0.000204	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.16e-06	0.000201	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.08e-06	0.000198	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	5.06e-06	0.000198	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.04e-06	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	5.02e-06	0.000196	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—Alzheimer's disease	5.01e-06	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—Alzheimer's disease	4.99e-06	0.000195	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.99e-06	0.000195	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	4.93e-06	0.000193	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	4.91e-06	0.000192	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.89e-06	0.000191	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.89e-06	0.000191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	4.85e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	4.83e-06	0.000189	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.79e-06	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—Alzheimer's disease	4.79e-06	0.000187	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.54e-06	0.000177	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.49e-06	0.000175	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	4.39e-06	0.000172	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	4.38e-06	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.29e-06	0.000167	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.2e-06	0.000164	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.18e-06	0.000163	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.16e-06	0.000162	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.14e-06	0.000162	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.77e-06	0.000147	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.75e-06	0.000147	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.73e-06	0.000146	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	3.72e-06	0.000145	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.71e-06	0.000145	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	3.69e-06	0.000144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.64e-06	0.000142	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.58e-06	0.00014	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—Alzheimer's disease	3.57e-06	0.000139	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.57e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	3.43e-06	0.000134	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	3.42e-06	0.000134	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	3.42e-06	0.000133	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	3.41e-06	0.000133	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.26e-06	0.000127	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.17e-06	0.000124	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	3.16e-06	0.000123	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.13e-06	0.000122	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.94e-06	0.000115	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.91e-06	0.000113	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	2.9e-06	0.000113	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.86e-06	0.000112	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.74e-06	0.000107	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.73e-06	0.000107	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.71e-06	0.000106	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—Alzheimer's disease	2.41e-06	9.4e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.39e-06	9.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	2.38e-06	9.31e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.38e-06	9.3e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—Alzheimer's disease	2.34e-06	9.12e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.19e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.18e-06	8.52e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.05e-06	8e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.02e-06	7.89e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.01e-06	7.86e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.87e-06	7.31e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.44e-06	5.62e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.41e-07	3.68e-05	CbGpPWpGaD
